Drawing for ZPECIMEN

USPTO serial 88234426

ZPECIMEN

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
KAPLAN, VALERIE ELIZABETH
Law office
TMEG LAW OFFICE 107 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with ZPECIMEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

No Attorney Available Yet

244-970 BurrardVancouver, 98072CANADA

Goods and services

ClassDescriptionStatusFirst use
001biological tissue specimens for use in scientific research cord blood for medical purposes;electrolyte drinks for medical purposes;genetic identity tests comprised of reagents for medical purposes;preparations for detecting genetic predispositions for medical purposes;reagents for use in medical genetic testing;vitamin enriched water for medical use;diagnostic preparations for medical laboratory use;disinfectants for medical instruments. humanoid robots with artificial intelligence;laboratory robots;laboratory instruments for the detection of pathogens and toxins in a biological samples; disposable gloves for medical purposes; medical devices for the qualitative detection of antibodies in human specimens collected as plasma or dried blood spots;medical specimen cups;blood collection bags for medical purposes;blood for medical purposes;containers especially adapted for the disposal of medical instruments and syringes and other contaminated medical waste. advertising by transmission of on-line publicity for third parties through electronic communications networks;chatroom services for social networking;business consulting in the field of business networking;on-line advertising for others on computer networks;operating marketplaces. operation of a website containing blood and sample collection schedules;operation of a website in the field of blood collection, sample and specimen collection, and genetic materials collection; operation of a website and app connecting health care professionals to patients;leasing of storage space;physical storage of electronically stored data or documents;providing information about storage;refrigeration storage;rental of storage containers;warehouse storage services. cryogenic preservation. genetic counselling;genetic testing for medical purposes;genetic testing of animals;genetic testing of animals for diagnostic or treatment purposes;analysing body composition of humans or animals for medical or veterinary purposes;conducting of medical examinations;DNA screening for medical purposes;leasing of medical equipment;medical analysis services for the diagnosis of cancer;medical and nursing services for the elderly;medical care and analysis services relating to patient treatment;medical clinics;medical consultancy for selecting appropriate wheelchairs, commodes, invalid hoists, walking frames and beds;medical consultancy relating to hearing loss;medical diagnostic services;medical laboratory services for the analysis of blood samples taken from patients;medical nursing services;medical testing services;mobile medical clinic services;fertility clinics;fertility treatment;medical services in the field of in vitro fertilization;medical equipment rental;medical examination services; medical house call services. Internet-based social introduction services;Internet-based social networking services;leasing access time to a computer database;on-line social networking services;operation of a website that provides online social networking;social introduction agency services;providing information about phlebotomy services via a websiteACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Dec 1, 2021MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Dec 1, 2021ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 20, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 20, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 20, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 20, 2021NREVNOTICE OF REVIVAL - E-MAILED—
Apr 19, 2021PETGPETITION TO REVIVE-GRANTED—
Apr 19, 2021PROATEAS PETITION TO REVIVE RECEIVED—
Feb 17, 2021MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 17, 2021ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 3, 2020GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Aug 3, 2020GNSIINQUIRY TO SUSPENSION E-MAILED—
Aug 3, 2020CNSISUSPENSION INQUIRY WRITTEN—
Feb 3, 2020GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Feb 3, 2020GNSLLETTER OF SUSPENSION E-MAILED—
Feb 3, 2020CNSLSUSPENSION LETTER WRITTEN—
Jan 10, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 10, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 10, 2020ALIEASSIGNED TO LIE—
Dec 18, 2019NREVNOTICE OF REVIVAL - E-MAILED—
Dec 17, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 17, 2019PETGPETITION TO REVIVE-GRANTED—
Dec 17, 2019PROATEAS PETITION TO REVIVE RECEIVED—
Oct 17, 2019MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 17, 2019ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 21, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 21, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 21, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 13, 2019DOCKASSIGNED TO EXAMINER—
Jan 10, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—

Frequently asked questions

Related guidance